01706nam a2200337 a 4500001001200000003000800012006001900020007001500039008004100054020001500095020001800110040002100128035002100149050002500170110003300195245036200228260005700590300002800647504005100675533015200726650003700878650003800915655002900953700002400982700001901006700002301025710008701048710009001135710001701225856012601242ebr10488621CaPaEBRm        u        cr cn|||||||||110827s2011    dcua    sb    001 0 eng d  z0309212219  z9780309212212  aCaPaEBRcCaPaEBR  a(OCoLC)75471498414aQP562.G5bP36 2011eb2 aInstitute of Medicine (U.S.)10aGlutamate-related biomarkers in drug development for disorders of the nervous systemh[electronic resource] :bworkshop summary /cDiana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board of Population Health and Public Health Practice, Institute of Medicine of the National Academies.  aWashington, D.C. :bNational Academies Press,c2011.  axii, 61 p. :bcol. ill.  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aGlutamic acidxPharmacokinetics. 0aCentral nervous systemxDiseases. 7aElectronic books.2local1 aPankevich, Diana E.1 aDavis, Miriam.1 aAltevogt, Bruce M.2 aInstitute of Medicine (U.S.).bForum on Neuroscience and Nervous System Disorders.2 aInstitute of Medicine (U.S.).bBoard of Population Health and Public Health Practice.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10488621zAn electronic book accessible through the World Wide Web; click to view